9.27 (35.26%)Mean Reversion
Neutral
Trend
Neutral
Event
Neutral
Mqv
Very Weak
Garp
Very Weak
Mqv Small
Neutral
Value
Consensus
Price
Weak
Earnings
Strong
Earnings
Weak
Dividends
Very Weak
Capital Efficiency
Very Weak
Balance Sheet
Strong
Website
Immunovant Inc
Telephone
1.917.580.3099
Address
Suite 210, 1000 Park Forty Plaza, Durham, NC 27713
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 13.79 - 30.16
Trade Value (12mth)
US$8,234,424.00
1 week
-4.37%
1 month
-7.04%
YTD
1.47%
1 year
82.44%
All time high
53.75
EPS 3 yr Growth
59.30%
EBITDA Margin
NaN%
Operating Cashflow
-$368m
Free Cash Flow Return
0.00%
ROIC
0.00%
Interest Coverage
0.00
Quick Ratio
0.00
Shares Outstanding (Fully Diluted)
182m
HALO Sector
Healthcare
Next Company Report Date
02-Jun-27
Next Ex Dividend Date
N/A
Next Dividend Pay Date
N/A
Reporting Currency
USD
Short Sell (% of issue)
0.00
| Date | Announcements |
| 20 May 26 | |
| 20 May 26 | |
| 20 May 26 | |
| 20 May 26 | |
| 06 February 26 |
Historical data
Forecast data
| USD | 2021 | 2022 | 2023 | 2024 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |||
| Per Share, Growth & Valuations | |||||||||||||
EPS (Basic) | $ |  | | | | -1.88 | -2.73 | -2.73 | | | | ||
EPS (Fully Diluted) | $ | | | | | -1.88 | -2.73 | N/A | | | | ||
Growth | % | | | | | -9.6 | -45.4 | N/A | | | | ||
PE | X | | | | | N/A | N/A | N/A | | | | ||
EV/EBITDA | X | | | | | N/A | N/A | N/A | | | | ||
Ex Dividend Date (est.)
DIV Yield
Franking Level
DPSg
Quality Yield
Falling Divs over next 2
Consensus Score
Recommendation
EPS 1 month Change
Quality Yield
Falling Divs over next 2
